Investment Analysts’ Upgrades for March 5th (ABUS, AIG, ALV, ANET, BDX, CARR, CB, CDZI, CLH, CSWC)

Investment Analysts’ upgrades for Wednesday, March 5th:

Arbutus Biopharma (NASDAQ:ABUS) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

American International Group (NYSE:AIG) was upgraded by analysts at HSBC Holdings plc from a hold rating to a buy rating. They currently have $93.00 price target on the stock.

Autoliv (NYSE:ALV) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Arista Networks (NYSE:ANET) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. UBS Group AG currently has $115.00 target price on the stock, up from their previous target price of $112.00.

Becton, Dickinson and Company (NYSE:BDX) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Carrier Global (NYSE:CARR) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. They currently have $78.00 price target on the stock, up from their previous price target of $77.00.

Chubb (NYSE:CB) was upgraded by analysts at HSBC Holdings plc from a hold rating to a buy rating. They currently have $323.00 target price on the stock.

Cadiz (NASDAQ:CDZI) was upgraded by analysts at StockNews.com to a sell rating.

Clean Harbors (NYSE:CLH) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Capital Southwest (NASDAQ:CSWC) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Clearway Energy (NYSE:CWEN) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Dillard’s (NYSE:DDS) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

The GEO Group (NYSE:GEO) was upgraded by analysts at Noble Financial from a market perform rating to an outperform rating. They currently have $32.00 price target on the stock.

GE Vernova (NYSE:GEV) was upgraded by analysts at Guggenheim from a neutral rating to a buy rating. Guggenheim currently has $380.00 target price on the stock.

Barrick Gold (NYSE:GOLD) (TSE:ABX) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. UBS Group AG currently has $22.00 target price on the stock.

Hyatt Hotels (NYSE:H) was upgraded by analysts at Evercore ISI from an in-line rating to an outperform rating. Evercore ISI currently has $175.00 target price on the stock.

Home Bancorp (NASDAQ:HBCP) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Intuit (NASDAQ:INTU) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. They currently have $660.00 target price on the stock, up from their previous target price of $640.00.

Jones Lang LaSalle (NYSE:JLL) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating.

Molina Healthcare (NYSE:MOH) was upgraded by analysts at Wells Fargo & Company from an equal weight rating to an overweight rating. They currently have $372.00 target price on the stock, up from their previous target price of $295.00.

Mosaic (NYSE:MOS) was upgraded by analysts at Barclays PLC from an underweight rating to an equal weight rating. They currently have $27.00 price target on the stock.

Nathan’s Famous (NASDAQ:NATH) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating.

Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR) was upgraded by analysts at HSBC Holdings plc from a hold rating to a buy rating. The firm currently has $15.00 target price on the stock.

Peoples Bancorp of North Carolina (NASDAQ:PEBK) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Park-Ohio (NASDAQ:PKOH) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Palantir Technologies (NASDAQ:PLTR) was upgraded by analysts at William Blair from an underperform rating to a market perform rating.

Permian Resources (NYSE:PR) was upgraded by analysts at Susquehanna from a neutral rating to a positive rating. Susquehanna currently has $20.00 price target on the stock, up from their previous price target of $17.00.

Royal Caribbean Cruises (NYSE:RCL) was upgraded by analysts at Loop Capital from a hold rating to a buy rating. They currently have $250.00 target price on the stock.

RadNet (NASDAQ:RDNT) was upgraded by analysts at Raymond James from an outperform rating to a strong-buy rating. The firm currently has $65.00 target price on the stock, down from their previous target price of $85.00.

ResMed (NYSE:RMD) was upgraded by analysts at Citigroup Inc. from a neutral rating to a buy rating.

Sumitomo Mitsui Financial Group (NYSE:SMFG) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Summit Therapeutics (NASDAQ:SMMT) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Sonoco Products (NYSE:SON) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Sysco (NYSE:SYY) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating.

Telefónica (NYSE:TEF) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Truist Financial (NYSE:TFC) was upgraded by analysts at Robert W. Baird from a neutral rating to an outperform rating. The firm currently has $52.00 price target on the stock, up from their previous price target of $48.00.

Tredegar (NYSE:TG) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Unum Group (NYSE:UNM) was upgraded by analysts at Raymond James from a market perform rating to a strong-buy rating. Raymond James currently has $108.00 price target on the stock.

United Parcel Service (NYSE:UPS) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Advanced Drainage Systems (NYSE:WMS) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Waterstone Financial (NASDAQ:WSBF) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Receive News & Ratings for Arbutus Biopharma Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arbutus Biopharma Co and related companies with MarketBeat.com's FREE daily email newsletter.